These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22726230)

  • 1. Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer.
    Harlid S; Butt S; Ivarsson MI; Eyfjörd JE; Lenner P; Manjer J; Dillner J; Carlson J
    BMC Womens Health; 2012 Jun; 12():17. PubMed ID: 22726230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
    Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
    Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
    Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study.
    Li H; Beeghly-Fadiel A; Wen W; Lu W; Gao YT; Xiang YB; Cai Q; Long J; Shi J; Chen K; Zheng Y; Shu XO; Zheng W
    Am J Epidemiol; 2013 Jan; 177(2):161-70. PubMed ID: 23221726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
    Obazee O; Justenhoven C; Winter S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Hannelius U; Li J; Humphreys K; Hall P; Giles G; Severi G; Baglietto L; Southey M; Rabstein S; Harth V; Lotz A; Pesch B; Brüning T; Baisch C; Ko YD; Hamann U; Brauch H
    Breast Cancer Res Treat; 2013 Apr; 138(2):543-8. PubMed ID: 23430226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
    Milne RL; Gaudet MM; Spurdle AB; Fasching PA; Couch FJ; Benítez J; Arias Pérez JI; Zamora MP; Malats N; Dos Santos Silva I; Gibson LJ; Fletcher O; Johnson N; Anton-Culver H; Ziogas A; Figueroa J; Brinton L; Sherman ME; Lissowska J; Hopper JL; Dite GS; Apicella C; Southey MC; Sigurdson AJ; Linet MS; Schonfeld SJ; Freedman DM; Mannermaa A; Kosma VM; Kataja V; Auvinen P; Andrulis IL; Glendon G; Knight JA; Weerasooriya N; Cox A; Reed MW; Cross SS; Dunning AM; Ahmed S; Shah M; Brauch H; Ko YD; Brüning T; ; Lambrechts D; Reumers J; Smeets A; Wang-Gohrke S; Hall P; Czene K; Liu J; Irwanto AK; Chenevix-Trench G; Holland H; ; ; Giles GG; Baglietto L; Severi G; Bojensen SE; Nordestgaard BG; Flyger H; John EM; West DW; Whittemore AS; Vachon C; Olson JE; Fredericksen Z; Kosel M; Hein R; Vrieling A; Flesch-Janys D; Heinz J; Beckmann MW; Heusinger K; Ekici AB; Haeberle L; Humphreys MK; Morrison J; Easton DF; Pharoah PD; García-Closas M; Goode EL; Chang-Claude J
    Breast Cancer Res; 2010; 12(6):R110. PubMed ID: 21194473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.
    Schoeps A; Rudolph A; Seibold P; Dunning AM; Milne RL; Bojesen SE; Swerdlow A; Andrulis I; Brenner H; Behrens S; Orr N; Jones M; Ashworth A; Li J; Cramp H; Connley D; Czene K; Darabi H; Chanock SJ; Lissowska J; Figueroa JD; Knight J; Glendon G; Mulligan AM; Dumont M; Severi G; Baglietto L; Olson J; Vachon C; Purrington K; Moisse M; Neven P; Wildiers H; Spurdle A; Kosma VM; Kataja V; Hartikainen JM; Hamann U; Ko YD; Dieffenbach AK; Arndt V; Stegmaier C; Malats N; Arias Perez JI; Benítez J; Flyger H; Nordestgaard BG; Truong T; Cordina-Duverger E; Menegaux F; dos Santos Silva I; Fletcher O; Johnson N; Häberle L; Beckmann MW; Ekici AB; Braaf L; Atsma F; van den Broek AJ; Makalic E; Schmidt DF; Southey MC; Cox A; Simard J; Giles GG; Lambrechts D; Mannermaa A; Brauch H; Guénel P; Peto J; Fasching PA; Hopper J; Flesch-Janys D; Couch F; Chenevix-Trench G; Pharoah PD; Garcia-Closas M; Schmidt MK; Hall P; Easton DF; Chang-Claude J
    Genet Epidemiol; 2014 Jan; 38(1):84-93. PubMed ID: 24248812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition, parity, age at first childbirth and risk for breast cancer.
    Butt S; Harlid S; Borgquist S; Ivarsson M; Landberg G; Dillner J; Carlson J; Manjer J
    BMC Res Notes; 2012 Aug; 5():414. PubMed ID: 22867275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
    Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
    Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy regimens and breast cancer risk(1).
    Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
    Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with breast cancer.
    Chacon-Cortes D; Smith RA; Lea RA; Youl PH; Griffiths LR
    Tumour Biol; 2015 Jul; 36(7):5369-76. PubMed ID: 25680407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of low-penetrant SNPs on breast cancer risk.
    Harlid S; Ivarsson MI; Butt S; Grzybowska E; Eyfjörd JE; Lenner P; Försti A; Hemminki K; Manjer J; Dillner J; Carlson J
    Br J Cancer; 2012 Jan; 106(2):389-96. PubMed ID: 22045194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
    Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
    Joshi AD; Lindström S; Hüsing A; Barrdahl M; VanderWeele TJ; Campa D; Canzian F; Gaudet MM; Figueroa JD; Baglietto L; Berg CD; Buring JE; Chanock SJ; Chirlaque MD; Diver WR; Dossus L; Giles GG; Haiman CA; Hankinson SE; Henderson BE; Hoover RN; Hunter DJ; Isaacs C; Kaaks R; Kolonel LN; Krogh V; Le Marchand L; Lee IM; Lund E; McCarty CA; Overvad K; Peeters PH; Riboli E; Schumacher F; Severi G; Stram DO; Sund M; Thun MJ; Travis RC; Trichopoulos D; Willett WC; Zhang S; Ziegler RG; Kraft P;
    Am J Epidemiol; 2014 Nov; 180(10):1018-27. PubMed ID: 25255808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.
    Feigelson HS; Jonas CR; Teras LR; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):220-4. PubMed ID: 14973094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.
    Nickels S; Truong T; Hein R; Stevens K; Buck K; Behrens S; Eilber U; Schmidt M; Häberle L; Vrieling A; Gaudet M; Figueroa J; Schoof N; Spurdle AB; Rudolph A; Fasching PA; Hopper JL; Makalic E; Schmidt DF; Southey MC; Beckmann MW; Ekici AB; Fletcher O; Gibson L; Silva Idos S; Peto J; Humphreys MK; Wang J; Cordina-Duverger E; Menegaux F; Nordestgaard BG; Bojesen SE; Lanng C; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Brauch H; Brüning T; Harth V; ; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; ; Lambrechts D; Smeets D; Neven P; Paridaens R; Flesch-Janys D; Obi N; Wang-Gohrke S; Couch FJ; Olson JE; Vachon CM; Giles GG; Severi G; Baglietto L; Offit K; John EM; Miron A; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Chanock SJ; Lissowska J; Liu J; Cox A; Cramp H; Connley D; Balasubramanian S; Dunning AM; Shah M; Trentham-Dietz A; Newcomb P; Titus L; Egan K; Cahoon EK; Rajaraman P; Sigurdson AJ; Doody MM; Guénel P; Pharoah PD; Schmidt MK; Hall P; Easton DF; Garcia-Closas M; Milne RL; Chang-Claude J
    PLoS Genet; 2013; 9(3):e1003284. PubMed ID: 23544014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).
    Lahmann PH; Hoffmann K; Allen N; van Gils CH; Khaw KT; Tehard B; Berrino F; Tjønneland A; Bigaard J; Olsen A; Overvad K; Clavel-Chapelon F; Nagel G; Boeing H; Trichopoulos D; Economou G; Bellos G; Palli D; Tumino R; Panico S; Sacerdote C; Krogh V; Peeters PH; Bueno-de-Mesquita HB; Lund E; Ardanaz E; Amiano P; Pera G; Quirós JR; Martínez C; Tormo MJ; Wirfält E; Berglund G; Hallmans G; Key TJ; Reeves G; Bingham S; Norat T; Biessy C; Kaaks R; Riboli E
    Int J Cancer; 2004 Sep; 111(5):762-71. PubMed ID: 15252848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.